Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy - Wikidata - wikimedia - TriplyDB

Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy

Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy

http://www.wikidata.org/entity/Q35652502

about

Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells A new prospect in cancer therapy: targeting cancer stem cells to eradicate cancer Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells Transcriptome sequencing of tumor subpopulations reveals a spectrum of therapeutic options for squamous cell lung cancer Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy.Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer.HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Enrichment and characterization of cancer stem‑like cells from a cervical cancer cell line.Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations.Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors Mammosphere formation assay from human breast cancer tissues and cell lines.Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.Sensitization of chemo-resistant human chronic myeloid leukemia stem-like cells to Hsp90 inhibitor by SIRT1 inhibition.All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy.Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment Diagnostic value of Wilms tumor 1 and CD44 in Langerhans cell sarcoma: case series of 4 patients.Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity Activation of RARα induces autophagy in SKBR3 breast cancer cells and depletion of key autophagy genes enhances ATRA toxicity.CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.Low concentrations of 5-aza-2'-deoxycytidine induce breast cancer stem cell differentiation by triggering tumor suppressor gene expression.The implications of cancer stem cells for cancer therapy.Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results.Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.CD44 targets Na(+)/H(+) exchanger 1 to mediate MDA-MB-231 cells' metastasis via the regulation of ERK1/2.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.Redox regulation in stem-like cancer cells by CD44 variant isoforms.CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.The cancer stem cell hypothesis: a guide to potential molecular targets.Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancer.Biological and clinical significance of cancer stem cell plasticity Altered fate of tendon-derived stem cells isolated from a failed tendon-healing animal model of tendinopathy.Increased invasion and tumorigenicity capacity of CD44+/CD24- breast cancer MCF7 cells in vitro and in nude mice.Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack.A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells.

P2860

Q26853528-E4868A48-2D84-4FDD-9ABE-F8E44FD46E1B Q27022134-90FCE632-2DE2-4564-B8F2-48A632B8076D Q28393898-D81D2473-8002-47DE-B296-90141E140F16 Q28488566-4B7861C2-1698-4074-BB75-CE8EF7186A82 Q31123584-5B427DEE-34D3-4FF3-B984-14FD12498879 Q33700204-438C0CC8-7BC3-44A3-B557-05AB18365428 Q33737278-AB7A1F0A-1DAF-4E74-9214-4E60BC48973C Q33747768-8EF06521-9147-4043-ADD9-71AA22900E02 Q33942068-D2CFD6CF-C131-4F4C-9922-33EA7620C579 Q34383397-EA58470D-27E7-4284-B742-837722B73016 Q35063763-B28B30F1-39E6-4889-A22B-5ACF3775368B Q35181463-33F57541-079C-4F9E-A0CB-A4B8489DF4EE Q35425337-4D0EBD41-2487-4AFF-B47D-5F8AD6FDF085 Q35460919-DE3706DE-A07D-4B06-A924-4F791EED5949 Q35550186-9637BB94-9B47-4467-8DF1-B740B5373251 Q35830047-AACB8A04-7A12-447C-A826-536443E6EE85 Q35977057-0935C174-9452-4DAD-9635-C85F8097A625 Q35979751-95F66D2A-FB7C-4B11-8359-4246AE365971 Q36009181-8A35EC31-35BB-4E41-985A-50CA4A748177 Q36014411-74FA1A84-23E9-46E7-B418-32EA7DD0352D Q36022328-B792CF57-FA02-459E-B8E8-41F883D15BAF Q36260608-29E7C430-A964-43F4-B8E0-73C63A5F3E85 Q36412709-5431A0DB-1C52-40F1-94CA-43B1B5705084 Q36538487-70EA3840-F7B0-4007-BE9A-8567C66567F1 Q37039311-11E0D4FE-7C5B-4798-A03F-DE2C868C8E77 Q37123297-01E361EB-2970-4BAC-88A4-19B0DE0EEB73 Q37295465-BE65F129-C745-4F44-B7DC-AA8C2D2C8F7E Q37420064-D694B5AE-70E5-44B5-9415-8FFB7CB5FB6C Q37594390-5A99757F-BCF0-4674-AF7E-03BB35AAE503 Q37610799-F681A227-7BEB-4DC6-A191-FFC2630C3F57 Q38045265-ED716917-0EFE-4785-994A-38743C583F17 Q38075424-B40F7A1A-0F90-4960-91C4-57E3A3F65320 Q38100108-326B8373-7C7F-4A18-9FC5-1664049B103E Q38254181-7D495838-9F6C-43D7-8A9C-EF374D08A07B Q38727418-6A336EA4-4456-4EBF-A553-8A987E45BC85 Q38757074-C999413C-B73F-4AF5-A72C-8BF845C69219 Q39293996-2C7F9CAD-6F10-4DC6-859C-19A3F89D2AB9 Q39396696-C55362AC-0E49-4543-9D90-DA8D9D543DBA Q39443694-DBA72CC1-82DF-4717-B457-573FC1C93F90 Q42049959-7A23AE2E-5A80-479D-B682-DE66D90E7B55

P2860

Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy

http://www.wikidata.org/entity/Q35652502

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Differentiation of breast canc ...... mising differentiation therapy

@ast

Differentiation of breast canc ...... mising differentiation therapy

@en

type

label

Differentiation of breast canc ...... mising differentiation therapy

@ast

Differentiation of breast canc ...... mising differentiation therapy

@en

prefLabel

Differentiation of breast canc ...... mising differentiation therapy

@ast

Differentiation of breast canc ...... mising differentiation therapy

@en

P1433

Q35652502-DBC5F2B5-9CBE-47AF-A1EA-67DB396C6A6C

P1476

Q35652502-962B1061-99BE-492B-811A-AD9BE1E190E8

P2093

Q35652502-3D6FD6C2-70A9-476A-95AD-065AE50A6450

Q35652502-45E3B278-1D77-418B-9D31-F5C7E61F5D3B

Q35652502-6643650B-777E-46A2-A744-32C9699A15A6

Q35652502-8D26AFCC-E1D8-4E08-9DEB-A186793009B1

Q35652502-A34B6659-6F9C-4AAB-A645-30DD1EC143EB

Q35652502-AA31724C-5370-431E-848A-62D1E4D76377

Q35652502-E59B740C-BC53-4F6F-833A-ED0D277C5F28

Q35652502-F4F971EA-2EFF-47B3-98AF-45B047048F42

P2860

Q35652502-03D609E9-4508-42D1-B18E-2932A504F517

Q35652502-08780B51-8551-48BA-9530-FE16DDC2CF23

Q35652502-09E628C4-3A29-4023-8E1C-EAA13B58CFF1

Q35652502-0A96651B-3553-40D1-BAD5-80AE98FEDBEA

Q35652502-16619F14-3ACA-42EE-B19F-32EFAB231154

Q35652502-16FDD058-F881-4CFD-BCF3-86EEDEA6E00C

Q35652502-17FA5F55-0CB9-4F4D-AD5D-12523903BC65

Q35652502-1CDAD2E9-85EC-4DE8-9CFA-1248E7058BC5

Q35652502-1F88B4B7-2E70-41C7-922B-A572BD98E663

Q35652502-2577AD12-29D9-43C2-95FE-FAF79CC02C61

P2888

Q35652502-C3BAEADA-E628-428E-9309-706235B00966

P304

Q35652502-D9B643BC-377B-420B-9A0E-4D43C2146389

P31

Q35652502-7EE232C1-CD8C-457F-8C50-72D91D5967CB

P356

Q35652502-0F569CAD-E092-4B09-88CA-320E19806EB0

P478

Q35652502-7A3E9B05-E07C-4444-BA72-CAEE1466AE67

P577

Q35652502-BCAC1009-820B-4A0F-A66D-298249A36B47

P5875

Q35652502-C0E46191-8DAD-47E1-9F79-615D5CE3CF74

P6179

Q35652502-B6CAF2B4-3FB1-435A-9BE6-27E832AE89F7

P698

Q35652502-ECA5F2DB-7A86-40CB-9662-E461A7B04B3D

P932

Q35652502-3D97C9AE-822A-465D-9C0C-F25FCC861E5E

P356

1479-5876-9-209

P1433

Journal of Translational Medicine

P1476

Differentiation of breast canc ...... mising differentiation therapy

@en

P2093

Dong V Le

http://www.w3.org/2001/XMLSchema#string

Kiet D Truong

http://www.w3.org/2001/XMLSchema#string

Ngoc K Phan

http://www.w3.org/2001/XMLSchema#string

Nhan L C Phan

http://www.w3.org/2001/XMLSchema#string

Nhung H Truong

http://www.w3.org/2001/XMLSchema#string

Nhung T Nguyen

http://www.w3.org/2001/XMLSchema#string

Phuc V Pham

http://www.w3.org/2001/XMLSchema#string

Thuy T Duong

http://www.w3.org/2001/XMLSchema#string

P2860

MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy

Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response

Mammary stem cells, self-renewal pathways, and carcinogenesis

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition

Prospective identification of tumorigenic breast cancer cells

ErbB receptors: from oncogenes to targeted cancer therapies

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

Mucin and Toll-like receptors in host defense against intestinal parasites

MUC1, the renaissance molecule

Mucins in cancer: protection and control of the cell surface

P2888

1479-5876-9-209

P304

209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-9-209

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51862333

http://www.w3.org/2001/XMLSchema#string

P6179

1007742602

http://www.w3.org/2001/XMLSchema#string

P698

22152097

http://www.w3.org/2001/XMLSchema#string

P932

3251542

http://www.w3.org/2001/XMLSchema#string